Literature DB >> 18786546

AKAP149 binds to HIV-1 reverse transcriptase and is involved in the reverse transcription.

Julie Lemay1, Priscilla Maidou-Peindara, Reynel Cancio, Eric Ennifar, Gaël Coadou, Giovanni Maga, Jean-Christophe Rain, Richard Benarous, Lang Xia Liu.   

Abstract

Like all retroviruses, human immunodeficiency virus type 1 (HIV-1) undergoes reverse transcription during its replication cycle. The cellular cofactors potentially involved in this process still remain to be identified. We show here that A-kinase anchoring protein 149 (AKAP149) interacts with HIV-1 reverse transcriptase (RT) in both the yeast two-hybrid system and human cells. The AKAP149 binding site has been mapped to the RNase H domain of HIV-1 RT. AKAP149 silencing by RNA interference in HIV-1-infected cells inhibited viral replication at the reverse transcription step. We selected single-point mutants of RT defective for AKAP149 binding and demonstrated that mutant G462R, despite retaining significant intrinsic RT activity in vitro, failed to carry out HIV-1 reverse transcription correctly in infected cells. This suggests that the interaction between RT and AKAP149 in infected cells may play an important role in HIV-1 reverse transcription.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18786546     DOI: 10.1016/j.jmb.2008.08.055

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  11 in total

Review 1.  A-kinase anchoring proteins as potential drug targets.

Authors:  Jessica Tröger; Marie C Moutty; Philipp Skroblin; Enno Klussmann
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 2.  Networking with AKAPs: context-dependent regulation of anchored enzymes.

Authors:  Emily J Welch; Brian W Jones; John D Scott
Journal:  Mol Interv       Date:  2010-04

Review 3.  Insights into cellular factors that regulate HIV-1 replication in human cells.

Authors:  Andrew M L Lever; Kuan-Teh Jeang
Journal:  Biochemistry       Date:  2011-01-24       Impact factor: 3.162

4.  The RNA binding protein HuR does not interact directly with HIV-1 reverse transcriptase and does not affect reverse transcription in vitro.

Authors:  Jinwoo Ahn; In-Ja L Byeon; Sanjeewa Dharmasena; Kelly Huber; Jason Concel; Angela M Gronenborn; Nicolas Sluis-Cremer
Journal:  Retrovirology       Date:  2010-05-07       Impact factor: 4.602

5.  Strand transfer and elongation of HIV-1 reverse transcription is facilitated by cell factors in vitro.

Authors:  David Warrilow; Kylie Warren; David Harrich
Journal:  PLoS One       Date:  2010-10-06       Impact factor: 3.240

6.  Quantitative phosphoproteomics reveals extensive cellular reprogramming during HIV-1 entry.

Authors:  Jason A Wojcechowskyj; Chuka A Didigu; Jessica Y Lee; Nicholas F Parrish; Rohini Sinha; Beatrice H Hahn; Frederic D Bushman; Shane T Jensen; Steven H Seeholzer; Robert W Doms
Journal:  Cell Host Microbe       Date:  2013-05-15       Impact factor: 21.023

7.  Reverse Transcriptase and Cellular Factors: Regulators of HIV-1 Reverse Transcription.

Authors:  Kylie Warren; David Warrilow; Luke Meredith; David Harrich
Journal:  Viruses       Date:  2009-11-10       Impact factor: 5.048

8.  Specific Interaction between eEF1A and HIV RT Is Critical for HIV-1 Reverse Transcription and a Potential Anti-HIV Target.

Authors:  Dongsheng Li; Ting Wei; Daniel J Rawle; Fangyun Qin; Rui Wang; Dinesh C Soares; Hongping Jin; Haran Sivakumaran; Min-Hsuan Lin; Kirsten Spann; Catherine M Abbott; David Harrich
Journal:  PLoS Pathog       Date:  2015-12-01       Impact factor: 6.823

9.  HIV-1-associated PKA acts as a cofactor for genome reverse transcription.

Authors:  Charline Giroud; Nathalie Chazal; Bernard Gay; Patrick Eldin; Sonia Brun; Laurence Briant
Journal:  Retrovirology       Date:  2013-12-17       Impact factor: 4.602

Review 10.  Molecular Mechanisms for cAMP-Mediated Immunoregulation in T cells - Role of Anchored Protein Kinase A Signaling Units.

Authors:  Vanessa L Wehbi; Kjetil Taskén
Journal:  Front Immunol       Date:  2016-06-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.